F C Jensen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F C Jensen

Showing results (51-60 of 59) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 59 results.

AIDS Research and Human Retroviruses|February 1, 1992

Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6F Ferre, A Marchese, P C Duffy, et al.

The Journal of Infectious Diseases|June 1, 1994

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cellsR J Trauger, F Ferre, A E Daigle, et al.

Journal of Clinical Immunology|September 1, 1996

Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIV-1 immunogen and antiviral drug therapyR B Moss, F Ferre, A Levine, et al.

The Journal of Infectious Diseases|August 7, 1999

Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogenR B Moss, M R Wallace, W K Giermakowska, et al.

Journal of Virology|April 1, 1986

Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndromeP N Fultz, H M McClure, R B Swenson, et al.

Immunology|April 1, 1993

Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burdenR J Trauger, W K Giermakowska, F Ferre, et al.

Journal of Human Virology|April 9, 1999

Tumor necrosis factor alpha and human immunodeficiency virus-specific functional immune responses after immunization with Gp120-depleted, inactivated HIV-1 in incomplete Freund's adjuvant (REMUNE) in HIV-1-seropositive subjectsR B Moss, L Li, W K Giermakowska, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1997

Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infectionR B Moss, R J Trauger, W K Giermakowska, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996

Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-upA M Levine, S Groshen, J Allen, et al.

Pageof 6

Search research articles

Showing results (51-60 of 59) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 59 results.

AIDS Research and Human Retroviruses|February 1, 1992

Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6F Ferre, A Marchese, P C Duffy, et al.

The Journal of Infectious Diseases|June 1, 1994

Journal of Clinical Immunology|September 1, 1996

Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIV-1 immunogen and antiviral drug therapyR B Moss, F Ferre, A Levine, et al.

The Journal of Infectious Diseases|August 7, 1999

Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogenR B Moss, M R Wallace, W K Giermakowska, et al.

Journal of Virology|April 1, 1986

Immunology|April 1, 1993

Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burdenR J Trauger, W K Giermakowska, F Ferre, et al.

Journal of Human Virology|April 9, 1999

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1997

Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infectionR B Moss, R J Trauger, W K Giermakowska, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1996

Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-upA M Levine, S Groshen, J Allen, et al.

Pageof 6